Menu

Antibiotics Linked to Childhood Obesity

Taking multiple courses of common antibiotics before the age of 2 may increase a child’s risk of obesity.

Oct 1, 2014
Jef Akst

WIKIMEDIA, RAYNATAWith rates of childhood obesity on the rise, researchers are searching for potential causes. One contributing factor, according to a study published in JAMA Pediatrics this week (September 29), may be antibiotics prescribed at a young age.

According to the study, which surveyed health records of more than 64,000 children, antibiotic use before the age of 2 is associated with increased obesity risk before age 5. Those children who were given four or more courses of common antibiotics before age 2 were at particularly high risk of developing childhood obesity. Strikingly, 69 percent of children studied had been given antibiotics in their first two years of life.

“Our hope is that we can find out what the risk factors are in early childhood and do a better job not just at preventing this, but of identifying the kids . . . who then can change their path by changing their lifestyle and changing the healthcare they get,” study author Charles Bailey of the Children’s Hospital of Philadelphia told Time.

Broad-spectrum antibiotics, which kill a range of different bacteria, appeared to drive this association; narrow-spectrum antibiotics did not show a significant link with childhood obesity. “[I]f we use broad-spectrum antibiotics a lot of the time, are we creating unintended effects down the road that we didn’t appreciate when we were sitting in the office?” Bailey told Time.

One possible mechanism that would link antibiotic use and obesity are the drugs’ effects on the body’s commensal microorganisms, which have been linked to metabolic changes. “It’s coming in every direction. We’re really assaulting our microbiome,” Martin Blaser, director of the Human Microbiome Program at New York University and author of Missing Microbes: How the Overuse of Antibiotics is Fueling Our Modern Plagues, told USA Today. “Right now, everyone is giving antibiotics, thinking they are ‘free,’” he adds. “Once there is evidence that they have costs, the calculation begins to change.”

Clarification (October 2, 2014): The subhead for this story has been updated to clarify that this is an observational study, and antibiotic use was simply correlated with increased risk of obesity. The Scientist regrets the confusion.

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Application of TruBIOME™ to Increase Mouse Model Reproducibility
Application of TruBIOME™ to Increase Mouse Model Reproducibility
With this application note from Taconic, learn about the effects of the microbiome on reproducibility and predictability and how TruBIOME™ helps researchers generate custom microbiota mouse models!
Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.